AbbVie, AndroGel partner owe US$448 million in antitrust case: US judge
A U.S. judge on Friday found that Abbvie Inc used sham litigation to illegally prevent generic versions of testosterone gel AndroGel from getting to market and ordered the drugmaker and its partner to pay US$488 million.
from Latest News https://ift.tt/2KlcuT2
from Latest News https://ift.tt/2KlcuT2
Comments
Post a Comment